Short-sighted policies, clickbait savings, and long-term damage to IBD patients
Short-sighted policies, clickbait savings, and long-term damage to IBD patients December 18, 2019 Gail Attara President & Chief Executive Officer, Gastrointestinal Society President, Canadian Society of Intestinal Research Alberta’s policy decision to switch the treatments of thousands of patients to biosimilars comes under the guise of presumed cost-savings and at the behest of a [...]